Elinzanetant approved as first dual NK-1 and NK-3 blocker for menopausal hot flashes
A new drug profile describes elinzanetant as the first dual NK-1 and NK-3 receptor antagonist approved for moderate to severe ...
A new drug profile describes elinzanetant as the first dual NK-1 and NK-3 receptor antagonist approved for moderate to severe ...
A network analysis of nearly 8,000 Mexican adults found that the correlations among cardiometabolic biomarkers undergo a sharp, sex-specific reorganization ...
A study combining retrospective human DXA data and mouse experiments reports that statins promote bone formation in estrogen deficiency by ...
Four leading U.S. medical societies have jointly published the first shared framework and clinical guidance linking women's cardiovascular risk to ...
A new American Heart Association-led series in Circulation outlines a female-specific life-course approach connecting hormonal changes, mental health and cardiovascular ...
An observational analysis of more than 2,700 women in the SWAN cohort linked hormone therapy initiated during peri- or early ...
A new review proposes that declining estradiol during the menopause transition may weaken cardiovascular mitochondria by reducing PGC-1 coactivator signaling, ...
A systematic review and meta-analysis of 21 studies finds that women in perimenopause and postmenopause report higher odds of anxiety ...
A review proposes that ovarian aging is a progressive reorganization of immune, metabolic, and endocrine networks linking the ovary to ...
An observational study of nearly 110,000 menopausal women found modestly higher autoimmune-disease hazards with estrogen-only therapy than with estrogen-plus-progestogen therapy, ...
A survey of nearly 100 male partners in Canada and the United Kingdom identified limited menopause knowledge, unmet support needs, ...
A propensity-matched cohort study found that testosterone therapy was associated with a higher hazard of composite cardiovascular disease in postmenopausal ...
A large retrospective cohort found that hormone-therapy use was associated with greater, sustained semaglutide weight loss in midlife women, while ...
A scoping review found preliminary evidence that lisdexamfetamine and atomoxetine may improve self-reported executive function during menopause, with little or ...
In an observational study of 51 postmenopausal women, combined estrogen and testosterone therapy was associated with a significant increase in ...
Laboratory, computational and human tissue analyses suggest that neurokinin receptor antagonists reduce breast cancer cell viability and suppress invasion-related pathways, ...
A large Chinese cohort study shows that lymphocyte subsets in women undergo a pronounced reconfiguration around menopause, with B cell ...
A new narrative review proposes that periodontal inflammation may amplify genitourinary vulnerability during and after menopause through systemic inflammatory signals ...
Experts warn in The BMJ that the rapid growth of private testosterone prescribing risks overtreatment, unclear diagnostics, and a hidden ...
A proteomic study of 28 healthy ovaries from women aged 50 to 75 reveals that the organ undergoes progressive molecular ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.